FILIPPI, MASSIMO
 Distribuzione geografica
Continente #
AS - Asia 39.517
NA - Nord America 25.159
EU - Europa 16.850
SA - Sud America 12.023
AF - Africa 796
OC - Oceania 124
Continente sconosciuto - Info sul continente non disponibili 36
AN - Antartide 1
Totale 94.506
Nazione #
US - Stati Uniti d'America 23.931
SG - Singapore 17.859
BR - Brasile 10.023
CN - Cina 9.474
HK - Hong Kong 5.853
SE - Svezia 4.679
IT - Italia 3.466
VN - Vietnam 3.253
RU - Federazione Russa 2.015
DE - Germania 1.641
GB - Regno Unito 899
AR - Argentina 853
FI - Finlandia 787
RO - Romania 740
IN - India 653
CA - Canada 582
MX - Messico 451
AT - Austria 399
NL - Olanda 395
EC - Ecuador 354
BD - Bangladesh 347
ZA - Sudafrica 332
ID - Indonesia 324
PL - Polonia 315
FR - Francia 311
IE - Irlanda 268
JP - Giappone 268
TR - Turchia 264
ES - Italia 256
IQ - Iraq 218
PY - Paraguay 173
CO - Colombia 167
IR - Iran 144
UA - Ucraina 131
VE - Venezuela 125
CL - Cile 124
MA - Marocco 122
LT - Lituania 115
AU - Australia 111
PK - Pakistan 111
PE - Perù 95
UZ - Uzbekistan 87
SA - Arabia Saudita 85
AE - Emirati Arabi Uniti 75
CH - Svizzera 73
EG - Egitto 73
UY - Uruguay 69
TN - Tunisia 66
KE - Kenya 64
DZ - Algeria 59
BE - Belgio 55
IL - Israele 55
PT - Portogallo 49
CZ - Repubblica Ceca 45
DO - Repubblica Dominicana 45
KR - Corea 44
KZ - Kazakistan 40
AZ - Azerbaigian 39
AL - Albania 37
BO - Bolivia 34
JO - Giordania 34
TW - Taiwan 31
NP - Nepal 30
MY - Malesia 25
OM - Oman 24
JM - Giamaica 23
NO - Norvegia 22
HN - Honduras 21
KW - Kuwait 21
LB - Libano 21
CR - Costa Rica 20
DK - Danimarca 20
KG - Kirghizistan 20
EU - Europa 19
ET - Etiopia 18
GR - Grecia 18
BG - Bulgaria 16
PA - Panama 15
SN - Senegal 15
TT - Trinidad e Tobago 15
BY - Bielorussia 14
PS - Palestinian Territory 14
BA - Bosnia-Erzegovina 13
BH - Bahrain 13
CY - Cipro 13
GE - Georgia 13
TH - Thailandia 13
NI - Nicaragua 12
GT - Guatemala 11
NG - Nigeria 11
SK - Slovacchia (Repubblica Slovacca) 11
SV - El Salvador 11
AM - Armenia 10
PH - Filippine 10
A1 - Anonimo 9
BB - Barbados 9
BN - Brunei Darussalam 8
EE - Estonia 8
HR - Croazia 8
MD - Moldavia 8
Totale 94.369
Città #
Dallas 7.949
Singapore 7.366
Hong Kong 5.806
Ashburn 2.682
Hefei 2.493
Shanghai 2.445
Lawrence 1.863
Princeton 1.862
Ho Chi Minh City 1.202
Beijing 1.147
Milan 971
New York 924
Moscow 920
São Paulo 898
Los Angeles 737
Hanoi 694
Helsinki 461
Munich 454
Boardman 421
Nuremberg 407
Rio de Janeiro 316
Rome 294
Warsaw 266
Dublin 257
Montreal 250
Tokyo 223
Denver 219
Brooklyn 212
Orem 198
Johannesburg 193
Belo Horizonte 192
Curitiba 188
Stockholm 188
Vienna 183
Poplar 180
Chennai 179
London 179
Santa Clara 175
Brasília 174
Mexico City 168
Lappeenranta 160
Pune 155
Chicago 153
Turku 152
Atlanta 151
The Dalles 147
Houston 144
Porto Alegre 143
Washington 140
Frankfurt am Main 136
Guangzhou 134
Amsterdam 133
Boston 133
Phoenix 132
Biên Hòa 124
Da Nang 124
Manchester 122
Ankara 120
Guayaquil 120
Salvador 120
Seattle 119
Campinas 116
Haiphong 115
Toronto 106
Quito 98
Tianjin 98
Fortaleza 96
Ribeirão Preto 90
Shenzhen 87
Guarulhos 83
Sydney 79
Tashkent 77
Buenos Aires 76
Thái Bình 75
Dhaka 72
Council Bluffs 71
Hải Dương 70
Baghdad 69
Querétaro 67
Cesano Boscone 66
Goiânia 66
Asunción 65
Sorocaba 65
Santo André 64
Lima 63
Turin 62
Hangzhou 61
Manaus 61
Mumbai 59
San Francisco 59
Montevideo 58
Falkenstein 57
Nairobi 56
Brescia 55
Caxias do Sul 55
São Bernardo do Campo 55
Naples 54
Paris 54
Recife 54
Charlotte 53
Totale 51.585
Nome #
10kin1day: A bottom-up neuroimaging initiative 2.212
The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study 316
Erratum to: Multiple sclerosis (Nature Reviews Disease Primers, (2018), 4, 1, (43), 10.1038/s41572-018-0041-4) 308
Awareness impairment in Alzheimer's disease and frontotemporal dementia: a systematic MRI review 238
A window into the mind-brain-body interplay: Development of diagnostic, prognostic biomarkers, and rehabilitation strategies in functional motor disorders 224
Stool Glial Fibrillary Acidic Protein Is Elevated in Progressive Multiple Sclerosis 193
A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis 161
A multicentric investigation of the diagnostic accuracy of cortical lesions and central vein sign in multiple sclerosis 156
Resting State Functional Connectivity Changes of the Pons in Migraine Patients: A Cross-Sectional and Longitudinal Study 152
A novel scoring approach to identify responders to erenumab in clinical practice 152
Resting State Effective Connectivity Abnormalities of the Papez Circuit Contribute to Explain Worse Cognitive Performances in Multiple Sclerosis Patients (P1-1.Virtual) 150
Epidural electrical stimulation facilitates motor recovery in spinal cord injury involving the conus medullaris: A case study 147
Functional correlates of intelligence quotient and cognitive abilities vary according to maturation in pediatric MS 146
Functional MRI of the Spinal Cord 143
Selecting structural MRI predictors of cognitive status in MS patients through a machine learning approach applied to a large multicenter MS population 143
Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci 143
High-frequency epidural electrical stimulation reduces spasticity and facilitates walking recovery in patients with spinal cord injury 140
Application of Deep-Learning to NMOSD and Seronegative Patients with Limited NMOSD Manifestations 140
2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis 139
Assessing treatment response to oral drugs for multiple sclerosis in real world setting: a MAGNIMS study 138
Sporadic Fatal Insomnia presenting with agrypnia excitata and rapidly progressive dementia: a case report 137
Impact of Multiple Sclerosis on Cognitive Aging: A Multicenter Study 137
Characterizing 1-Year Development of Cervical Cord Atrophy Across Different Ms Phenotypes: A Voxel-Wise, Multicenter Analysis 136
The HTT gene influences plasma neurofilament light chain and brain metabolism in prodromal Alzheimer’s disease 133
Cardiorespiratory fitness and free-living physical activity are not associated with cognition in persons with progressive multiple sclerosis: baseline analyses from the COGEX study 133
Cognitive and MRI profile in primary and secondary progressive multiple sclerosis 131
A comparison of MR imaging with fast-FLAIR, HASTE-FLAIR, and EPI-FLAIR sequences in the assessment of patients with multiple sclerosis 130
Dynamic functional connectivity of thalamic sub-regions shows divegent patterns in multiple sclerosis phenotypes 129
XGBoost vs. TabPFN in Neuroimaging Machine Learning-based analysis 126
The brief repeatable battery of neuropsychological tests (BRB-N) version a: update of Italian normative data from the Italian Neuroimaging Network Initiative (INNI) 124
A composite score to predict short-term disease activity in patients with relapsing-remitting MS 120
Real-word application of the AT(N) classification and disease-modifying treatment eligibility in a hospital-based cohort 120
A comparison between the sensitivities of 3-mm and 5-mm thick serial brain MRI for detecting lesion volume changes in patients with multiple sclerosis 119
Gray matter damage predicts the accumulation of disability 13 years later in MS. 119
A Deep Learning Approach to Predicting Disease Progression in Multiple Sclerosis Using Magnetic Resonance Imaging 119
Alterations of brain structural MRI are associated with outcome of surgical treatment in trigeminal neuralgia 118
2.5-Year changes of connectivity dynamism are relevant for physical and cognitive deterioration in multiple sclerosis 116
A conventional and magnetization transfer MRI study of the cervical cord in patients with MS 116
A 3-year diffusion tensor MRI study of grey matter damage progression during the earliest clinical stage of MS 115
A functional MRI study of cortical activations associated with object manipulation in patients with multiple sclerosis 113
A common marker of affect recognition dysfunction in the FTD spectrum of disorders 112
A functional magnetic resonance imaging study of patients with secondary progressive multiple sclerosis 111
Action Observation and Motor Imagery Improve Dual Task in Parkinson's Disease: A Clinical/fMRI Study 111
Clinical and neuroanatomical characterization of the semantic behavioral variant of frontotemporal dementia in a multicenter Italian cohort 110
A functional MRI study of cortical activations associated with object manipulation in patients with MS 110
A comparison of multimodal evoked potentials, nuclear magnetic resonance imaging and CSF profile for the diagnosis of multiple sclerosis. 109
Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access 108
The association between cognition and motor performance is beyond structural damage in relapsing–remitting multiple sclerosis 107
Favorable long-term cognitive outcomes following recurrent ARIA linked to amyloid-lowering therapies: two cases 107
Effects of atidarsagene autotemcel gene therapy on peripheral nerves in late-infantile metachromatic leukodystrophy 106
A brain MRI study of different types of chronic-progressive multiple sclerosis 106
Glymphatic system impairment in multiple sclerosis: relation with brain damage and disability 105
Voxel-wise multimodal MRI reveals specific patterns of brain damage in the main multiple sclerosis phenotypes 104
Amyloid-Related Imaging Abnormalities and β-Amyloid-Targeting Antibodies: A Systematic Review 104
fMRI of the Sensorimotor System 103
Current perspectives on the diagnosis and management of fatigue in multiple sclerosis 103
A 3-Year Magnetic Resonance Imaging Study of Cortical Lesions in Relapse-Onset Multiple Sclerosis 102
A comparison of the sensitivity of monthly unenhanced and enhanced MRI techniques in detecting new multiple sclerosis lesions 101
Cognitive Reserve Modulates the Impact of Structural Damage of the Frontal Lobe on Executive Functioning in Multiple Sclerosis (P1-1.Virtual) 100
Correspondence among gray matter atrophy and atlas-based neurotransmitter maps is clinically relevant in multiple sclerosis 99
Correction to: Sporadic Fatal Insomnia presenting with agrypnia excitata and rapidly progressive dementia: a case report (Journal of Neurology, (2023), 10.1007/s00415-023-11605-5) 99
250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study 99
A brain magnetization transfer MRI study with a clinical follow up of about four years in patients with clinically isolated syndromes suggestive of multiple sclerosis 98
Towards imaging criteria that best differentiate MS from NMOSD and MOGAD: Large multi-ethnic population and different clinical scenarios 98
A diffusion tensor magnetic resonance imaging study of brain tissue from patients with migraine 97
Expanded and independent validation of the NoMoFA scale for Parkinson’s disease: the Italian version 97
DNA Methylation in the Anti-Mullerian Hormone Gene and the Risk of Disease Activity in Multiple Sclerosis 94
A 1-year serial clinical and MRI study of primary progressive multiple sclerosis 94
A Fully Automatic Method to Segment Choroid Plexuses in Multiple Sclerosis Using Conventional MRI Sequences 93
Cerebro-cerebellar motor networks in clinical subtypes of Parkinson's disease 93
A diffusion tensor MRI study of cervical cord damage in benign and secondary progressive multiple sclerosis patients 92
A comprehensive update on neuroimaging endpoints in amyotrophic lateral sclerosis 89
Sex-Related Differences in Upper Limb Motor Function in Healthy Subjects and Multiple Sclerosis Patients: A Multiparamenric MRI Study (P1-1.Virtual) 89
A functional MRI study of cortical activations associated with object manipulation in patients with multiple sclerosis 88
Case report: coexistence of C9orf72 expansion and progranulin mutation in a case of genetic frontotemporal dementia-clinical features and neuroimaging correlates 87
A functional MRI study of movement-associated cortical changes in patients with Devic's neuromyelitis optica 87
Gamma Knife radiosurgery as primary treatment of low-grade brainstem gliomas: A systematic review and metanalysis of current evidence and predictive factors 87
Virtual reality balance training to improve balance and mobility in Parkinson’s disease: a systematic review and meta-analysis 87
Choroid plexus enlargement in paediatric multiple sclerosis: clinical relevance and effect of sex 86
Refractory anti-NMDAR encephalitis successfully treated with bortezomib and associated movements disorders controlled with tramadol: a case report with literature review 86
Deep Learning on Conventional Magnetic Resonance Imaging Improves the Diagnosis of Multiple Sclerosis Mimics 86
Phenotypes and clinical subgroups in vestibular migraine: a cross-sectional study with cluster analysis 85
Modifiable risk factors of COVID-19 in patients with multiple sclerosis: a single-centre case-control study 85
A multiparametric MRI study of structural brain damage in dementia with lewy bodies: A comparison with Alzheimer's disease 85
Functional and structural brain MRI changes associated with cognitive worsening in multiple sclerosis: a 3-year longitudinal study 84
Neurofilament light chain as a biological marker for amyotrophic lateral sclerosis: a meta-analysis study 84
Amyotrophic Lateral Sclerosis-Frontotemporal Dementia: Shared and Divergent Neural Correlates Across the Clinical Spectrum 84
Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAFV600E mutation in a patient with overlapping Erdheim-Chester/Rosai-Dorfman disease 83
Resting State Functional Connectivity Correlates of Executive Function in Patients with Multiple Sclerosis 83
Correction to: Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association study (Journal of Neurology, (2024), 271, 11, (7250-7263), 10.1007/s00415-024-12608-6) 83
Clinical Features and Biomarkers to Differentiate Primary and Amyotrophic Lateral Sclerosis in Patients With an Upper Motor Neuron Syndrome 82
Ocrelizumab extended-interval dosing in multiple sclerosis during SARS-CoV-2 pandemic: a real-world experience 82
Brain-based classification of youth with anxiety disorders: transdiagnostic examinations within the ENIGMA-Anxiety database using machine learning 82
Immune-mediated colitis: A class effect with anti-CD2O agents used to treat MS? 82
Dual-task gait training improves cognition and resting-state functional connectivity in Parkinson’s disease with postural instability and gait disorders 82
A comparison of the sensitivity of MRI after double- and triple-dose Cd-DTPA for detecting enhancing lesions in multiple sclerosis 82
A diffusion tensor MRI study of patients with MCI and AD with a 2-year clinical follow-up 82
Unexpected (123I)FP-CIT SPECT findings: SWIDD, SWEDD and all DAT 82
Combining semi-quantitative rating and automated brain volumetry in MRI evaluation of patients with probable behavioural variant of fronto-temporal dementia: an added value for clinical practise? 81
Tumefactive Demyelination in MOG Ab-Associated Disease, Multiple Sclerosis, and AQP-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder 81
Totale 13.650
Categoria #
all - tutte 772.977
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 772.977


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021261 0 0 0 0 0 123 16 11 57 10 34 10
2021/20221.397 16 29 26 619 45 99 118 79 88 82 89 107
2022/20239.416 4.200 1.746 598 52 119 1.017 313 506 394 80 152 239
2023/20245.317 258 272 457 470 382 972 279 514 123 326 402 862
2024/202531.466 3.538 643 571 673 796 2.196 3.940 2.534 5.807 4.686 3.277 2.805
2025/202648.850 7.249 8.621 9.175 14.925 6.961 1.919 0 0 0 0 0 0
Totale 97.496